d3 Medicine

Certara acquires d3 Medicine

Thursday, September 8, 2016

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has acquired d3 Medicine. d3 Medicine, which is based in Parsippany, New Jersey, and Melbourne, Australia, provides strategic planning and stewardship of complex drug development programs.

[Read More]